GENITOURINARY TRACT NEOPLASM

This adverse event was reported 83 times

GENITOURINARY TRACT NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TEBENTAFUSP 1 0.0017
1 ADEFOVIR DIPIVOXIL 2 0.0016
2 BREXUCABTAGENE AUTOLEUCEL 3 0.0014
3 LANREOTIDE ACETATE 11 0.0014
4 MOSUNETUZUMAB 1 0.0009
5 AXICABTAGENE CILOLEUCEL 8 0.0008
6 LOPERAMIDE HCL 9 0.0007
7 CILTACABTAGENE AUTOLEUCEL 4 0.0006
8 GLOFITAMAB 1 0.0004
9 LANADELUMAB-FLYO 1 0.0003
See all drugs enriched for association with GENITOURINARY TRACT NEOPLASM